EIGHTEEN-MONTH INTERIM ANALYSIS OF EFFICACY AND SAFETY OF GIVOSIRAN, AN RNAI THERAPEUTIC FOR ACUTE HEPATIC PORPHYRIA, IN THE ENVISION OPEN LABEL EXTENSION D Kuter, S Keel, C Parker, DC Rees, U Stölzel, P Ventura, M Balwani, L Gouya, S Rhyee, S Silver

A PHASE 1/2 OPEN LABEL EXTENSION STUDY OF GIVOSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA R. Marchi, L. Duarte, S. P, R. D, A. Ke, B. Hl, S. E, H. P, B. M, E. Al

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA A.N.L. Prezotti, K.J. Pasi, C. Négrier, M.V. Ragni, P. Georgiev, T. Lissitchkov, K. Salim, B. Mei, S. Andersson